228 related articles for article (PubMed ID: 38329812)
41. Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.
Zhou Z; Lu H; Zhu S; Gomaa A; Chen Z; Yan J; Washington K; El-Rifai W; Dang C; Peng D
J Exp Clin Cancer Res; 2019 Jan; 38(1):13. PubMed ID: 30626422
[TBL] [Abstract][Full Text] [Related]
42. Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
Kelly RJ; Ansari AM; Miyashita T; Zahurak M; Lay F; Ahmed AK; Born LJ; Pezhouh MK; Salimian KJ; Ng C; Matsangos AE; Stricker-Krongrad AH; Mukaisho KI; Marti GP; Chung CH; Canto MI; Rudek MA; Meltzer SJ; Harmon JW
Ann Surg; 2021 Jun; 273(6):e206-e213. PubMed ID: 31290765
[TBL] [Abstract][Full Text] [Related]
43. Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.
Deissova T; Cvanova M; Kala Z; Jiraskova Zakostelska Z; Dolina J; Kunovsky L; Kroupa R; Pavlovsky Z; Lipovy B; Danek Z; Izakovicova Holla L; Urban O; Navratil V; Lischke R; Harustiak T; Grolich T; Prochazka V; Slaby O; Borilova Linhartova P
Dis Markers; 2022; 2022():8790748. PubMed ID: 36092955
[TBL] [Abstract][Full Text] [Related]
44. Role of Obesity, Physical Exercise, Adipose Tissue-Skeletal Muscle Crosstalk and Molecular Advances in Barrett's Esophagus and Esophageal Adenocarcinoma.
Bilski J; Pinkas M; Wojcik-Grzybek D; Magierowski M; Korbut E; Mazur-Bialy A; Krzysiek-Maczka G; Kwiecien S; Magierowska K; Brzozowski T
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409299
[TBL] [Abstract][Full Text] [Related]
45. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.
Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF
Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691
[TBL] [Abstract][Full Text] [Related]
46. Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage.
Molendijk J; Kolka CM; Cairns H; Brosda S; Mohamed A; Shah AK; Brown I; Hodson MP; Hennessy T; Liu G; Stoll T; Richards RS; Gartside M; Patel K; Clemons NJ; Phillips WA; Barbour A; Westerhuis JA; Hill MM
Clin Transl Med; 2022 May; 12(5):e810. PubMed ID: 35560527
[TBL] [Abstract][Full Text] [Related]
47. Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights.
Weh KM; Zhang Y; Howard CL; Howell AB; Clarke JL; Kresty LA
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267943
[TBL] [Abstract][Full Text] [Related]
48. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy.
O'Riordan JM; Tucker ON; Byrne PJ; McDonald GS; Ravi N; Keeling PW; Reynolds JV
Am J Gastroenterol; 2004 Feb; 99(2):205-11. PubMed ID: 15046206
[TBL] [Abstract][Full Text] [Related]
49. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen.
Goldstein SR; Yang GY; Curtis SK; Reuhl KR; Liu BC; Mirvish SS; Newmark HL; Yang CS
Carcinogenesis; 1997 Nov; 18(11):2265-70. PubMed ID: 9395230
[TBL] [Abstract][Full Text] [Related]
50. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
51. The Salivary Microbiome and Predicted Metabolite Production Are Associated with Barrett's Esophagus and High-Grade Dysplasia or Adenocarcinoma.
Solfisburg QS; Baldini F; Baldwin-Hunter B; Austin GI; Lee HH; Park H; Freedberg DE; Lightdale CJ; Korem T; Abrams JA
Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):371-380. PubMed ID: 38117184
[TBL] [Abstract][Full Text] [Related]
52. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
[TBL] [Abstract][Full Text] [Related]
53. The Immune Underpinnings of Barrett's-Associated Adenocarcinogenesis: a Retrial of Nefarious Immunologic Co-Conspirators.
Tambunting L; Kelleher D; Duggan SP
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1297-1315. PubMed ID: 35123116
[TBL] [Abstract][Full Text] [Related]
54. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
55. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.
Molendijk J; Nguyen TM; Brown I; Mohamed A; Lim Y; Barclay J; Hodson MP; Hennessy TP; Krause L; Morrison M; Hill MM
Biomolecules; 2020 May; 10(5):. PubMed ID: 32429496
[TBL] [Abstract][Full Text] [Related]
56. Bile acids but not acidic acids induce Barrett's esophagus.
Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
[TBL] [Abstract][Full Text] [Related]
57. Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
Sawada A; Fujiwara Y; Nagami Y; Tanaka F; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Gi M; Wanibuchi H; Arakawa T
Dig Dis Sci; 2016 Nov; 61(11):3161-3168. PubMed ID: 27461059
[TBL] [Abstract][Full Text] [Related]
58. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus.
Murphy SJ; Anderson LA; Ferguson HR; Johnston BT; Watson PR; McGuigan J; Comber H; Reynolds JV; Murray LJ; Cantwell MM
J Nutr; 2010 Oct; 140(10):1757-63. PubMed ID: 20702746
[TBL] [Abstract][Full Text] [Related]
59. Gene expression in Barrett's esophagus and reflux esophagitis induced by gastroduodenoesophageal reflux in rats.
Cheng P; Gong J; Wang T; Jie C; Liu GS; Zhang R
World J Gastroenterol; 2005 Jun; 11(21):3277-80. PubMed ID: 15929182
[TBL] [Abstract][Full Text] [Related]
60. Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma.
Guccione C; Yadlapati R; Shah S; Knight R; Curtius K
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
